RealEndpoints

Real Endpoints, a health-care advisory/analytics firm delivering solutions that enhance appropriate access to innovation.

[Adam J. Fein @DrugChannels]

From @RealEndpoints: A Solution to the #Medicare Copay Problem

Read the article: https://t.co/KHebSHVNYr

Register for the free webcast: https://t.co/j1ozfPBMfz

#ad

[RealEndpoints @RealEndpoints]

LAST CHANCE TO REGISTER

Join Real Endpoints on Wednesday, June 23rd as we share real-world insights into the preparation, negotiation, execution and reconciliation of innovative contracts to drive market access.

Register here: https://t.co/xggsMZ6ww9

[RealEndpoints @RealEndpoints]

Real Endpoints Marketplace for addressing high cost orphan medical benefit drugs is included in MIT’s white paper on emerging market solutions to address coverage and reimbursement challenges faced by durable #cellandgenetherapies.

Read Here: https://t.co/cHSmNSzsBE

[RealEndpoints @RealEndpoints]

With the #FDA’s landmark decision to approve #Aduhelm, payers are faced with an incredibly difficult decision – that is, how to provide affordable access to appropriate patients.

How do you think payers will respond?

https://t.co/OrEFqCEgH3

[RealEndpoints @RealEndpoints]

Real Endpoints CEO, Jeff Berkowitz, recently sat down with Life Science Leader to discuss his experiences and lessons learned from transitioning to an adjacent industry.

Read Jeff's advice for others who are considering the same. #careeradvice

https://t.co/XLdkahL8MI

[RealEndpoints @RealEndpoints]

ICER and experts at Memorial Sloan Kettering’s drug pricing lab review the process, challenges and potential reforms to the FDA's accelerated approval process.

Read here: https://t.co/vRrYpcFsOP

[RealEndpoints @RealEndpoints]

Do you know what employers are hearing, what they are looking for from payers, and how that will impact access for your brand? Hint: no free passes… #marketaccess #specialtypharmacy #biologics #pharma

Read Here: https://t.co/7Qo5TN6mm4

[RealEndpoints @RealEndpoints]

Manufacturers think CMS bars them from helping #Medicare patients afford their medicines. This is incorrect.

Join the RE webinar to understand how patient services can help ensure affordable access for Medicare Beneficiaries. #marketaccess

Register: https://t.co/tsKanb4wND

[RealEndpoints @RealEndpoints]

CVSHealth recently released their Health Trends Report 2021 highlighting the opportunities that continue to arise from the challenges of 2020. It’s no surprise that technology, from EHR’s to virtual care, continues to hold the spotlight. #marketaccess

https://t.co/INwGFqoO8h

[RealEndpoints @RealEndpoints]

So — do ICER evaluations really impact how companies price their products? Well, yeah.

#Marketaccess #pharma #healthcare #ICER #drugpricing

Read Here: https://t.co/dqNiy4BHcu

[RealEndpoints @RealEndpoints]

Last week #Amazon announced plans to expand #AmazonCare virtual health services nationally. This is another intentional step towards a disruptive model focused on becoming an integral part of the healthcare ecosystem and forcing change. #Pharma #telehealth
https://t.co/XOWv9pJnPf

[RealEndpoints @RealEndpoints]

#CellTherapy and #GeneTherapy continue to grow with 2021 likely to be a record year for the number of regulatory decisions on new regenerative medicine products. Payers continue to watch the evolution of this space closely to address challenges.

Read Here https://t.co/1XD19ER5YB

[RealEndpoints @RealEndpoints]

Worth reading the WSJ article on net-price declines for what it says, more for what it doesn’t. Net prices are decreasing in competitive spaces, but not in cancer/rare disease — which is where pharma is going. #pharma #healthcare #RareDisease #oncology

https://t.co/LiTIYQNZOY

[RealEndpoints @RealEndpoints]

Equity and inclusion are fundamental to enable each of us to bring our best to our teams and organizations every day. Real Endpoints celebrates #internationalwomensday2021 as we salute our female colleagues.

#ChooseToChallenge #WeCanDoIt #IWD2021 #IWD @womensday

[RealEndpoints @RealEndpoints]

Check out the @PharmaScrip 2021 Pharma Trends Report where Real Endpoints’ Founder and Chairman, @RealEndptsRog joins top industry thought leaders to provide predictions for the major trends facing the industry in 2021. #healthcare #marketaccess

See here: https://t.co/ivGuc68hGt

[RealEndpoints @RealEndpoints]

As we approach #RareDiseaseDay the #RealEndpoints team thinks about tackling the tough issues around coverage and reimbursement and assuring #PatientAccess @rarediseaseday #raredisease #pharmaceuticals #marketaccess

[RealEndpoints @RealEndpoints]

Can #pharma be doing more to reach patients from underrepresented groups and remove barriers? Partnering with @SHG_PerfectData and @RomAnalytics RE conducted a study to see if there were blind spots for PSS pertaining to diversity and inclusion.
Read here: https://t.co/TsUbNWRfac

[RealEndpoints @RealEndpoints]

Can the pharma industry capitalize on its recent rehab and benefit patients by using value based contracting? The RE Marketplace for VBCs is the perfect platform for partnering with payers.
Read here: https://t.co/dCe2icwZoA
Learn about RE Marketplace: https://t.co/3wSKSHDspu

[RealEndpoints @RealEndpoints]

Our CEO, @Berkowij joined @jimbojoyce and @HealthEugene for their podcast #TheShot of #DigitalHealth. Listen for a discussion on the early days of pharma market access, digital therapeutics, & #RealEndpoints revolutionary approach to VBAs.
Watch here: https://t.co/UAt9ERiaUu

[RealEndpoints @RealEndpoints]

Options, Expertise and Risk Tolerance say it all! The Real Endpoints Marketplace for #ValueBasedContracting addresses all of these. Contact us for expert support in developing and placing these arrangements.
Read on our LinkedIn: https://t.co/eoIkOeJZqY